Resources

Positions
Professor
Center for Gene Therapy
Baylor College of Medicine
Houston, TX US
Member
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas United States
Addresses
Houston Methodist Hospital (Work)6565 Fannin St., Suite 800
Houston, Texas 77030
United States
(713) 441-1450
Google Maps
Houston Methodist Hospital (Clinic)
6565 Fannin St., Suite 800
Houston, Texas 77030
United States
(713) 441-1450
Google Maps
Certifications
-
American Board of Internal Medicine
-
American Board of Internal Medicine, Medical Oncology
Education
-
MD from P.J. Nehru Medical College
Raipur India -
Residency at University of Tennessee College of Medicine
Memphis, TNInternal Medicine
-
Fellowship at University of Oklahoma Health Science Center
Oklahoma City, OKHematology and Oncology
-
Fellowship at All India Institute of Medical Sciences
New Delhi IndiaHematology and Oncology
-
Fellowship at University of Arkansas Medical School
Little Rock, ARHematology and Oncology
-
Fellowship at New York Hospital - Cornell Medical Center
New York City, NYHematology
Language
- English
Gender
- Male
Professional Statement
Dr. Kamble is Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC). Dr. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant. Dr. Kamble's clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease.
Professional Specialties
-
Hematology
-
Oncology